Tuesday, November 10, 2009

Heart Disease Home>
News>
Multaq approved for heart rhythm disorders

Font size
- A
- A
- A
Email This

Bookmark

Save

Multaq approved for heart rhythm disorders

(HealthScout) UPDATED 2009-07-02

The U.S. Food and Drug Administration has approved the drug Multaq to promote normal heart rhythm in people who suffer from atrial fibrillation or atrial flutter. These conditions can keep the heart from pumping blood effectively because they cause the heart to beat too quickly. The drug will carry a black box warning, however, warning users that the medication can cause a deadly reaction in people who have severe heart failure. Read full story >

See all Heart Disease News

Related: Multaq

Font size
- A
- A
- A
Email This
Bookmark

Was this helpful? Yes
Save

Note: All clinical content on this site is physician-reviewed, except material generated by our community members.

Non-Profit Affiliates:

Featuring Content From:

By using this service, you accept our Terms of Use. Please read them. The consumer health information on MyHeartCentral.com is for informational purposes only and is not a substitute for medical advice or treatment for any medical conditions. You should promptly seek professional medical care if you have any concern about your health, and you should always consult your physician before starting a fitness regimen. Copyright © 2005-2009. The HealthCentral Network, Inc. All rights reserved.

We comply with the HONcode standard for trustworthy health information: verify here.